Doxazosin EG (Doxazosina)

Doxazosina EG is a pharmaceutical product primarily used to treat hypertension (high blood pressure) and symptoms of benign prostatic hyperplasia. It belongs to the class of medications known as alpha-blockers. The EG brand (EuroGenerici) is a well-established name in the generic medicine market, providing affordable therapeutic alternatives to brand-name drugs.

Founded in Italy, EuroGenerici has grown into a major player in the European pharmaceutical landscape. Today, the brand is part of the STADA Group, a leading international pharmaceutical company headquartered in Germany. Manufacturing of Doxazosina EG takes place in various high-standard facilities across Europe and other regions to ensure a stable supply for the global healthcare market. STADA continues to oversee the production and distribution, maintaining the legacy of the original Italian generic pioneer while leveraging German pharmaceutical engineering and quality control standards.